Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

A review of dendritic cell therapy for cancer: progress and challenges.

Mantia-Smaldone GM, Chu CS.

BioDrugs. 2013 Oct;27(5):453-68. doi: 10.1007/s40259-013-0030-9. Review.

PMID:
23592406
2.

Immunotherapy with dendritic cells for cancer.

Ballestrero A, Boy D, Moran E, Cirmena G, Brossart P, Nencioni A.

Adv Drug Deliv Rev. 2008 Jan 14;60(2):173-83. Epub 2007 Oct 5. Review.

PMID:
17977615
3.

Dendritic cell-based combined immunotherapy with autologous tumor-pulsed dendritic cell vaccine and activated T cells for cancer patients: rationale, current progress, and perspectives.

Morisaki T, Matsumoto K, Onishi H, Kuroki H, Baba E, Tasaki A, Kubo M, Nakamura M, Inaba S, Yamaguchi K, Tanaka M, Katano M.

Hum Cell. 2003 Dec;16(4):175-82. Review.

PMID:
15147037
4.

Current status and future applications of cellular therapies for cancer.

Copier J, Bodman-Smith M, Dalgleish A.

Immunotherapy. 2011 Apr;3(4):507-16. doi: 10.2217/imt.11.18. Review.

PMID:
21463192
5.

Dendritic/tumor fusion cell-based vaccination against cancer.

Koido S, Hara E, Homma S, Fujise K, Gong J, Tajiri H.

Arch Immunol Ther Exp (Warsz). 2007 Sep-Oct;55(5):281-7. Review.

PMID:
18219758
6.

New perspectives in dendritic cell-based cancer immunotherapy.

Nencioni A, Brossart P.

BioDrugs. 2001;15(10):667-79. Review.

PMID:
11604048
7.

Dendritic cell gene therapy.

Onaitis M, Kalady MF, Pruitt S, Tyler DS.

Surg Oncol Clin N Am. 2002 Jul;11(3):645-60. Review.

PMID:
12487060
8.

Dendritic cells: still a promising tool for cancer immunotherapy.

Aragoneses-Fenoll L, Corbí AL.

Clin Transl Oncol. 2007 Feb;9(2):77-82. Review.

PMID:
17329218
9.

Novel perspectives on dendritic cell-based immunotherapy of cancer.

Bonaccorsi I, Pezzino G, Morandi B, Ferlazzo G.

Immunol Lett. 2013 Sep-Oct;155(1-2):6-10. doi: 10.1016/j.imlet.2013.09.021. Epub 2013 Sep 26. Review.

PMID:
24076312
10.

Dendritic cell vaccination and immune monitoring.

Aarntzen EH, Figdor CG, Adema GJ, Punt CJ, de Vries IJ.

Cancer Immunol Immunother. 2008 Oct;57(10):1559-68. doi: 10.1007/s00262-008-0553-y. Epub 2008 Jul 10. Review.

11.

Dendritic cells: a journey from laboratory to clinic.

Cerundolo V, Hermans IF, Salio M.

Nat Immunol. 2004 Jan;5(1):7-10. Review. No abstract available.

PMID:
14699398
12.
13.

Dendritic cell-based cancer immunotherapy.

Engleman EG.

Semin Oncol. 2003 Jun;30(3 Suppl 8):23-9. Review.

PMID:
12881809
14.

Dendritic-cell-based therapeutic cancer vaccines.

Palucka K, Banchereau J.

Immunity. 2013 Jul 25;39(1):38-48. doi: 10.1016/j.immuni.2013.07.004. Review.

15.

Dendritic cell-based vaccine research against cancer.

Mody N, Dubey S, Sharma R, Agrawal U, Vyas SP.

Expert Rev Clin Immunol. 2015 Feb;11(2):213-32. doi: 10.1586/1744666X.2015.987663. Epub 2014 Dec 3. Review.

PMID:
25467734
16.

Vaccine strategies for glioblastoma: progress and future directions.

Jackson C, Ruzevick J, Brem H, Lim M.

Immunotherapy. 2013 Feb;5(2):155-67. doi: 10.2217/imt.12.155. Review.

17.

Dendritic cells: are they clinically relevant?

Palucka K, Ueno H, Roberts L, Fay J, Banchereau J.

Cancer J. 2010 Jul-Aug;16(4):318-24. doi: 10.1097/PPO.0b013e3181eaca83. Review.

18.

The role of regulatory T lymphocytes in the induced immune response mediated by biological vaccines.

López M, Aguilera R, Pérez C, Mendoza-Naranjo A, Pereda C, Ramirez M, Ferrada C, Aguillón JC, Salazar-Onfray F.

Immunobiology. 2006;211(1-2):127-36. Epub 2006 Jan 4. Review.

PMID:
16446177
19.

Current state and perspectives of dendritic cell vaccination in cancer immunotherapy.

Farkas A, Conrad C, Tonel G, Borbenyi Z, Kemeny L, Dobozy A, Nestle FO.

Skin Pharmacol Physiol. 2006;19(3):124-31. Epub 2006 Apr 6. Review.

PMID:
16612139
20.

Dendritic cell-based vaccines in breast and gynaecologic cancer.

Hernando JJ, Park TW, Kuhn WC.

Anticancer Res. 2003 Sep-Oct;23(5b):4293-303. Review.

PMID:
14666641

Supplemental Content

Support Center